| Product: | Alverine Citrate | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Catalog Number: | 16279 | ||||||||
| CAS Number: | 5560-59-8 | ||||||||
| Synonyms: | N-Ethyl-3,3´-diphenlyldipropylamine; Alverine citrate salt | ||||||||
| Pricing: |
| ||||||||
| Formula: | C20H27N • C6H8O7 | ||||||||
| Molecular Weight: | 473.56 | ||||||||
| Structure: |  | ||||||||
| Appearance: | Solid | ||||||||
| Category: | Biochemicals and Reagents | ||||||||
| Stability: | Stable under recommended storage conditions | ||||||||
| Storage: | Keep container tightly closed in a dry and well-ventilated place | ||||||||
| Transportation: | Non-hazardous for transport | ||||||||
| Literature References: | G. Jansen, et al., Chemogenomic profiling predicts antifungal synergies Mol. Syst. Biol. 5, (2009);T. Wittmann, et al., Clinical trial: the efficacy of alverine citrate/simeticone combination on abdominal pain/discomport in irritable bowel syndrome - a randomized, double-blind, placebo-controlled study Aliment. Pharmacol. Ther. 31, 615-624, (2010);V. M. Gohil, et al., Nutrient-sensitized screening for drugs that shift energy metabolism from mitochondrial respiration to glycolysis Nat. Biotechnol. 28, 249-255, (2010);A. F. Fliri, et al., Drug Effects Viewed from a Signal Transduction Network Perspective J. Med. Chem. 52, 8038-8046, (2009);D. Ju, et al., Dyclonine and alverine citrate enhance the cytotoxic effects of proteasome inhibitor MG132 on breast cancer cells Int. J. Mol. Med. 23, 205-209, (2009);M. Hayase, et al., Evolving mechanisms of action of alverine citrate on phasic smooth muscles Br. J. Pharmacol. 152, 1228-1238, (2007); Merck 14,371 | ||||||||
| MSDS: | |||||||||
| Applications: | Used for studies of pharmacological activity including: |
